Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

CYTOKINETICS INC Director's Dealing 2015

May 21, 2015

30870_dirs_2015-05-21_d77d41d3-ea04-49ea-b34b-63e9962fc5af.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: CYTOKINETICS INC (CYTK)
CIK: 0001061983
Period of Report: 2015-05-20

Reporting Person: HENDERSON JOHN T (Director)

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2015-05-20 Stock Option (right to buy) $6.21 A 20000 Acquired 2025-05-20 Common Stock (20000) Direct

Footnotes

F1: This option shall vest and become exercisable in 12 equal monthly installments and shall become fully vested on May 20, 2016.